Nanobiotix S.A. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K is a report of a foreign private issuer filed by Nanobiotix S.A. for the month of November 2025. The filing, dated November 14, 2025, serves to incorporate by reference a press release issued on the same date (Exhibit 99.1). The registrant files annual reports under Form 20-F.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document acts as a conduit for a press release and does not contain embedded financial tables or statements.
Material Changes
The filing text does not provide a clear value regarding material changes versus the prior comparable period. Specific operational or financial changes are detailed in the attached press release, the content of which is not included in the provided text.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. These details are contained within the referenced press release (Exhibit 99.1).
Key Facts for Investor Verification
- Verify the content of the press release dated November 14, 2025, attached as Exhibit 99.1, as this filing contains no substantive data other than the reference.
- Confirm the specific announcement made by Nanobiotix S.A. on this date, as the Form 6-K itself is procedural.
- Note that the report was signed by Bart Van Rhijn, Chief Financial Officer.